These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12657237

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
    Pestieau SR, Schnake KJ, Stuart OA, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):269-76. PubMed ID: 11320672
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Laparoscopic peritoneal dialysis catheter implantation in peritoneal chemotherapy for gastric cancer with peritoneal metastasis].
    Ma JJ, Zang L, Yang ZY, Xie BW, Hong XZ, Cai ZH, Zhang LY, Yan C, Zhu ZG, Zheng MH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug 25; 22(8):774-780. PubMed ID: 31422617
    [Abstract] [Full Text] [Related]

  • 7. A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.
    Takahashi N, Kanda M, Yoshikawa T, Takiguchi N, Fujitani K, Miyamoto K, Ito Y, Takayama O, Imano M, Mitsumori N, Sakamoto J, Morita S, Kodera Y.
    Gastric Cancer; 2018 Nov 25; 21(6):1014-1023. PubMed ID: 29536296
    [Abstract] [Full Text] [Related]

  • 8. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
    Marchettini P, Stuart OA, Mohamed F, Yoo D, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2002 Jun 25; 49(6):499-503. PubMed ID: 12107555
    [Abstract] [Full Text] [Related]

  • 9. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
    Kodera Y, Ito Y, Ito S, Ohashi N, Mochizuki Y, Yamamura Y, Koike M, Fujiwara M, Nakanishi H, Nakao A.
    Hepatogastroenterology; 2007 Jun 25; 54(75):960-3. PubMed ID: 17591103
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S, Nao F, Kinami S, Ninomiya I, Fujimura T, Nishimura G, Ohta T, Yokogawa K, Miyamoto K, Miwa K.
    Gan To Kagaku Ryoho; 2002 Oct 25; 29(10):1759-63. PubMed ID: 12402426
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.
    Wei ZG, Li GX, Huang XC, Zhen L, Yu J, Deng HJ, Qing SH, Zhang C.
    World J Gastroenterol; 2008 Apr 14; 14(14):2179-86. PubMed ID: 18407591
    [Abstract] [Full Text] [Related]

  • 12. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.
    Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH.
    Oncology; 1998 Apr 14; 55(2):130-8. PubMed ID: 9499187
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.
    Ansaloni L, Coccolini F, Morosi L, Ballerini A, Ceresoli M, Grosso G, Bertoli P, Busci LM, Lotti M, Cambria F, Pisano M, Rossetti D, Frigerio L, D'Incalci M, Zucchetti M.
    Br J Cancer; 2015 Jan 20; 112(2):306-12. PubMed ID: 25461804
    [Abstract] [Full Text] [Related]

  • 14. A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.
    Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ.
    Cancer Chemother Pharmacol; 2015 May 20; 75(5):1075-87. PubMed ID: 25898813
    [Abstract] [Full Text] [Related]

  • 15. High Penetration of Paclitaxel in Abdominal Wall of Rabbits after Hyperthermic Intraperitoneal Administration of Nab-Paclitaxel Compared to Standard Paclitaxel Formulation.
    Coccolini F, Acocella F, Morosi L, Brizzola S, Ghiringhelli M, Ceresoli M, Davoli E, Ansaloni L, D'Incalci M, Zucchetti M.
    Pharm Res; 2017 Jun 20; 34(6):1180-1186. PubMed ID: 28247168
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S, Furui N, Kinami S, Ninomiya I, Fujimura T, Nishimura G, Ohta T, Yokogawa K, Miyamoto K, Miwa K.
    Gan To Kagaku Ryoho; 2002 Nov 20; 29(12):2164-7. PubMed ID: 12484028
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer.
    de Bree E, Rosing H, Beijnen JH, Romanos J, Michalakis J, Georgoulias V, Tsiftsis DD.
    Anticancer Drugs; 2003 Feb 20; 14(2):103-10. PubMed ID: 12569296
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.
    Simón-Gracia L, Hunt H, Scodeller PD, Gaitzsch J, Braun GB, Willmore AM, Ruoslahti E, Battaglia G, Teesalu T.
    Mol Cancer Ther; 2016 Apr 20; 15(4):670-9. PubMed ID: 26880267
    [Abstract] [Full Text] [Related]

  • 19. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
    Muñoz-Casares FC, Rufián S, Arjona-Sánchez Á, Rubio MJ, Díaz R, Casado Á, Naranjo Á, Díaz-Iglesias CJ, Ortega R, Muñoz-Villanueva MC, Muntané J, Aranda E.
    Cancer Chemother Pharmacol; 2011 Jul 20; 68(1):267-74. PubMed ID: 21499894
    [Abstract] [Full Text] [Related]

  • 20. Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
    Nicoletto MO, Dalla Palma M, Donach ME, Gusella M, Cappetta A, Shams M, Marchet A, Nardin M, Pintacuda G, Di Maggio A, Marchesi M, Carli P, Fiduccia P, Artioli G, Nitti D.
    Tumori; 2010 Jul 20; 96(6):918-25. PubMed ID: 21388052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.